SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-23-033593
Filing Date
2023-09-25
Accepted
2023-09-25 16:15:53
Documents
7

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 247757
2 ex5-1.htm EX-5.1 21052
3 ex23-1.htm EX-23.1 4345
4 ex107.htm EX-FILING FEES 21200
5 forms-3_001.jpg GRAPHIC 6270
6 image_001.jpg GRAPHIC 2884
7 ex5-1_002.jpg GRAPHIC 1510
  Complete submission text file 0001493152-23-033593.txt   310386
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

IRS No.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274684 | Film No.: 231276042
SIC: 2834 Pharmaceutical Preparations